Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.81+0.01 (+1.06%)
Close on Nov 17, 2026Market cap $104.43MP/E –Yield –
Organogenesis price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Organogenesis's price to sales ratio was 0.3× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.2× to 2.7×, with a median of 0.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | −1.1 |
| 2025 | Dec 31, 2025 | 1.4× | +0.5 |
| 2024 | Dec 31, 2024 | 0.9× | −0.3 |
| 2023 | Dec 29, 2023 | 1.2× | +0.4 |
| 2022 | Dec 30, 2022 | 0.8× | −1.9 |
| 2021 | Dec 31, 2021 | 2.7× | +0.0 |
| 2020 | Dec 31, 2020 | 2.6× | +0.8 |
| 2019 | Dec 31, 2019 | 1.8× | −1.8 |
| 2018 | Dec 31, 2018 | 3.7× | +1.9 |
| 2017 | Dec 29, 2017 | 1.8× | – |
See a number that looks wrong?